AU7137498A - Dna fragmentation factor involved in apoptosis - Google Patents
Dna fragmentation factor involved in apoptosisInfo
- Publication number
- AU7137498A AU7137498A AU71374/98A AU7137498A AU7137498A AU 7137498 A AU7137498 A AU 7137498A AU 71374/98 A AU71374/98 A AU 71374/98A AU 7137498 A AU7137498 A AU 7137498A AU 7137498 A AU7137498 A AU 7137498A
- Authority
- AU
- Australia
- Prior art keywords
- apoptosis
- dna fragmentation
- factor involved
- fragmentation factor
- involved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1998/007895 WO1999054482A1 (en) | 1998-04-16 | 1998-04-16 | Dna fragmentation factor involved in apoptosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7137498A true AU7137498A (en) | 1999-11-08 |
Family
ID=22266872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU71374/98A Abandoned AU7137498A (en) | 1998-04-16 | 1998-04-16 | Dna fragmentation factor involved in apoptosis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7137498A (en) |
WO (1) | WO1999054482A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10006889A1 (en) * | 2000-02-16 | 2001-09-06 | Procorde Gmbh | Use of inhibitors of caspase-3 or the caspase-activated deoxyribonuclease (CAD) for the treatment of heart diseases |
US6692736B2 (en) * | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
-
1998
- 1998-04-16 WO PCT/US1998/007895 patent/WO1999054482A1/en active Application Filing
- 1998-04-16 AU AU71374/98A patent/AU7137498A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999054482A1 (en) | 1999-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3485999A (en) | Neo-tryptophan | |
AU6101399A (en) | Bio-assay technique | |
AU2106399A (en) | Apoptosis inducing molecule ii | |
AU5970699A (en) | Use | |
AU3568799A (en) | Booklet | |
AU2975499A (en) | Road luge | |
AU3522399A (en) | Carvedilol-galenics | |
AU3437799A (en) | City-car | |
AU6417799A (en) | Matrix-remodeling genes | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU3253699A (en) | Myxochelines | |
AU5566799A (en) | Electrodes | |
AU1707599A (en) | Retinoid-glitazone combinations | |
AU7137498A (en) | Dna fragmentation factor involved in apoptosis | |
AU5998199A (en) | New bis-benzimidazoles | |
AU2609599A (en) | Sensor-coupling | |
AU7353500A (en) | Apoptosis proteins | |
AU3204999A (en) | Futureball | |
AU2069199A (en) | Codelets | |
AU8812098A (en) | In line filing of works | |
AU1676299A (en) | Improvements in flocculants | |
AUPP392898A0 (en) | Multi-web construction | |
AU5852000A (en) | Atopy gene | |
AU5314999A (en) | Modified oligonucleotides | |
AU3347599A (en) | Aeromobile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |